Anzeige
Mehr »
Sonntag, 01.03.2026 - Börsentäglich über 12.000 News
Erste Psilocybin-Behandlungen laufen - warum steht Optimi noch bei Pennystock-Level?!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: 938526 | ISIN: FR0000075954 | Ticker-Symbol: RI7
Tradegate
27.02.26 | 17:19
5,790 Euro
-2,03 % -0,120
Branche
Nanotechnologie
Aktienmarkt
Sonstige
1-Jahres-Chart
RIBER SA Chart 1 Jahr
5-Tage-Chart
RIBER SA 5-Tage-Chart
RealtimeGeldBriefZeit
5,7705,95028.02.
5,8605,94027.02.

Aktuelle News zur RIBER Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
03.02.Riber's full-year 2025 revenue falls by 2% to €40.3m, but second-half up 7% year-on-year2
02.02.RIBER: 2025 performance driven by production systems and the rollout of ROSIE3752025 performance driven by production systems and the rollout of ROSIE Revenues of €40.3 million in line with guidanceOrder book at December 31, 2025: €26.9 million (+24%) Bezons (France), February...
► Artikel lesen
RIBER Aktie jetzt für 0€ handeln
19.01.QD Laser orders Riber MBE 6000 to scale quantum dot laser production for datacoms11
19.01.Riber receives a new order from Japan for MBE 6000 to scale Quantum Dot Laser production for Datacom870Riber receives a new order from Japan for MBE 6000 to scale Quantum Dot Laser production for Datacom. Bezons (France), 19 January 2026 - 8:00 am (CET) - RIBER, a global market leader in molecular beam...
► Artikel lesen
29.12.25European firm orders two Riber MBE 6000 production systems5
29.12.25RIBER receives a major order in Europe for two MBE 6000 production systems, including associated services881RIBER receives a major order in Europe for two MBE 6000 production systems, including associated services Bezons (France), December 29, 2025 - 8:00 am - RIBER, a global market leader in molecular...
► Artikel lesen
01.10.25Riber's first-half 2025 revenue and earnings impacted by deliveries being concentrated into second-half1
25.09.252025 first-half earnings: RIBER confirms the rollout of its roadmap and its annual outlook8432025 first-half earnings: RIBER confirms the rollout of its roadmap and its annual outlook. Half-year revenues and earnings, particularly marked by seasonal activity patterns. Order book of €27.7m...
► Artikel lesen
17.09.25Riber receives Taiwanese order for Compact 21 DZ research MBE system8
17.09.25RIBER receives an order in Asia for a research system3
08.09.25New milestone for RIBER in silicon photonics with a ROSIE order in the United States1.334New milestone for RIBER in silicon photonics with a ROSIE order in the United States Bezons (France), 8 September 2025 - 8:00 am - RIBER, a global market leader in molecular beam epitaxy (MBE) equipment...
► Artikel lesen
18.08.25RIBER receives an order for two production systems in Asia1.294Bezons (France), August 18, 2025 - 8:00 am - RIBER, a global market leader in molecular beam epitaxy (MBE) equipment for the semiconductor industry, announces the order of two new MBE 6000 production...
► Artikel lesen
18.06.25RIBER reaffirms its strategic roadmap at the Annual General Meeting held on June 18, 20251.195RIBER reaffirms its strategic roadmap at the Annual General Meeting held on June 18, 2025 Bezons, June 18, 2025 - 5:45 PM - RIBER, a global market leader for molecular beam epitaxy (MBE) equipment...
► Artikel lesen
17.06.25RIBER completes phase I of ROSIE with a partnership agreement signed with NQCP, a leading research center in Denmark1.099RIBER completes phase I of ROSIE with a partnership agreement signed with NQCP, a leading research center in Denmark Bezons (France), June 17, 2025 - 6:00pm (CET) - RIBER, the global leader in...
► Artikel lesen
09.04.25RIBER reports solid growth in sales and earnings in 20241.607RIBER reports solid growth in sales and earnings in 2024 Revenues: €41.2m (+5%)Income from ordinary operations: €4.5m, representing 11% of revenues Net income: €4.1m (+21%)Proposed payout of €0.08...
► Artikel lesen
15 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1